Abstract
| Lingua originale | English |
|---|---|
| pagine (da-a) | 349-353 |
| Numero di pagine | 5 |
| Rivista | Default journal |
| Volume | 41 |
| Stato di pubblicazione | Published - 2006 |
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
Cita questo
High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400. / Lagalla, Roberto; Midiri, Massimo; De Monye, Cecile; De Feyter, Pim J.; Runza, Giuseppe; Mollet, Nico R.; Van Der Lugt, Aad; Cademartiri, Filippo; Krestin, Gabriel P.; Pugliese, Francesca; Runza, Giuseppe.
In: Default journal, Vol. 41, 2006, pag. 349-353.Risultato della ricerca: Article
}
TY - JOUR
T1 - High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400
AU - Lagalla, Roberto
AU - Midiri, Massimo
AU - De Monye, Cecile
AU - De Feyter, Pim J.
AU - Runza, Giuseppe
AU - Mollet, Nico R.
AU - Van Der Lugt, Aad
AU - Cademartiri, Filippo
AU - Krestin, Gabriel P.
AU - Pugliese, Francesca
AU - Runza, Giuseppe
PY - 2006
Y1 - 2006
N2 - OBJECTIVE: The objective of this study was to compare intracoronary attenuation on 16-row multislice computed tomography (16-MSCT) coronary angiography using 2 contrast materials (CM) with high iodine concentration. MATERIAL AND METHODS: Forty consecutive patients (29 male, 11 female; mean age, 61 ± 11 years) with suspected coronary artery disease were randomized to 2 groups to receive 100 mL of either iopromide 370 (group 1: Ultravist 370, 370 mg iodine/mL; Schering AG, Berlin, Germany) or iomeprol 400 (group 2: Iomeron 400, 400 mg iodine/mL; Bracco Imaging SpA, Milan, Italy). Both CM were administered at a rate of 4 mL/s. All patients underwent 16-MSCT coronary angiography (Sensation 16; Siemens, Germany) with collimation 16 × 0.75 mm and rotation time 375 ms. The attenuation in Hounsfield units (HU) achieved after each CM was determined at regions of interest (ROIs) placed at the origin of coronary arteries and on the ascending aorta, descending aorta, and pulmonary artery. Differences in mean attenuation in the coronary arteries and on the ascending aorta, descending aorta, and pulmonary artery were evaluated using Student t test. RESULTS: The mean attenuation achieved at each anatomic site was consistently greater after iomeprol 400 than after iopromide 370. At the origin of coronary arteries, the mean attenuation after iomeprol 400 (340 ± 53 HU) was greater (P < 0.05) than that after iopromide 370 (313 ± 42 HU). Similar findings were noted for the mean attenuation in the ascending aorta, descending aorta, and pulmonary artery. CONCLUSION: The intravenous administration of iomeprol 400 provides higher attenuation of the coronary arteries and of the great arteries of the thorax as compared with iopromide 370 using the same injection parameters. Copyright © 2006 by Lippincott Williams & Wilkins
AB - OBJECTIVE: The objective of this study was to compare intracoronary attenuation on 16-row multislice computed tomography (16-MSCT) coronary angiography using 2 contrast materials (CM) with high iodine concentration. MATERIAL AND METHODS: Forty consecutive patients (29 male, 11 female; mean age, 61 ± 11 years) with suspected coronary artery disease were randomized to 2 groups to receive 100 mL of either iopromide 370 (group 1: Ultravist 370, 370 mg iodine/mL; Schering AG, Berlin, Germany) or iomeprol 400 (group 2: Iomeron 400, 400 mg iodine/mL; Bracco Imaging SpA, Milan, Italy). Both CM were administered at a rate of 4 mL/s. All patients underwent 16-MSCT coronary angiography (Sensation 16; Siemens, Germany) with collimation 16 × 0.75 mm and rotation time 375 ms. The attenuation in Hounsfield units (HU) achieved after each CM was determined at regions of interest (ROIs) placed at the origin of coronary arteries and on the ascending aorta, descending aorta, and pulmonary artery. Differences in mean attenuation in the coronary arteries and on the ascending aorta, descending aorta, and pulmonary artery were evaluated using Student t test. RESULTS: The mean attenuation achieved at each anatomic site was consistently greater after iomeprol 400 than after iopromide 370. At the origin of coronary arteries, the mean attenuation after iomeprol 400 (340 ± 53 HU) was greater (P < 0.05) than that after iopromide 370 (313 ± 42 HU). Similar findings were noted for the mean attenuation in the ascending aorta, descending aorta, and pulmonary artery. CONCLUSION: The intravenous administration of iomeprol 400 provides higher attenuation of the coronary arteries and of the great arteries of the thorax as compared with iopromide 370 using the same injection parameters. Copyright © 2006 by Lippincott Williams & Wilkins
UR - http://hdl.handle.net/10447/27585
M3 - Article
VL - 41
SP - 349
EP - 353
JO - Default journal
JF - Default journal
ER -